Abstract
Coronavirus Disease 2019 (COVID-19) has infected more than 3.0 million people worldwide and killed more than 200,000 as of April 27, 2020. In this White Paper, we address the cardiovascular co-morbidities of COVID-19 infection; the diagnosis and treatment of standard cardiovascular conditions during the pandemic; and the diagnosis and treatment of the cardiovascular consequences of COVID-19 infection. In addition, we will also address various issues related to the safety of healthcare workers and the ethical issues related to patient care in this pandemic.
Original language | English |
---|---|
Pages (from-to) | e017013 |
Journal | Journal of the American Heart Association |
Volume | 9 |
Issue number | 12 |
Early online date | 29 Apr 2020 |
DOIs | |
Publication status | Published - 16 Jun 2020 |
Keywords
- COVID‐19
- Cardiovascular disease
- Coronavirus disease 2019
- SARS‐CoV‐2
- cardiovascular risk factors
- management
- treatment